Month: March 2019

ZAMBIAN GOVERNMENT WELCOMES ADOLESCENT HIV PREVENTION STUDY FINDINGS As the HIV epidemic continues to take its toll on Zambia, a new HIV prevention study on young people has found that most Zambian adolescents are HIV negative, but more needs to…

Research governance Zambart research governance is an independent entity that oversees the processes that ensure that all research conducted by Zambart is of high quality and that the rights and wellbeing of the participant that are recruited into a study…

Zambart is one of the study sites for a Phase IIb trial of a new TB vaccine. The trial is being conducted by Aeras and GlaxoSmithKline Vaccines, S.A. (GSK) and is a double-blind randomised, placebo controlled study. (Clinical Trail.gov Identifier:…

    Tuberculosis Reduction through Expanded Anti-Retroviral Treatment and Screening (TREATS) Project THE TREATS project (Tuberculosis Reduction through Expanded Anti-retroviral Treatment and Screening) aims to measure the impact of a household-level combined HIV and TB prevention intervention on the burden…

HIV Self-Testing Africa Project Zambart, is part of a consortium of partners conducting the four-year HIV Self-Testing Africa (STAR) Study in fourteen urban and rural communities in Zambia.  STAR is a three-country clinical research project comprising Zambia, Zimbabwe and Malawi,…